In an era of increasingly bespoke healthcare, Elizabeth Philp has established herself as a formidable force of innovation, particularly in the technologically advancing field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the vanguard of a drive to make custom medications more available, questioning the